Results 171 to 180 of about 345,246 (267)

Impact of Histopathological Response on Outcomes After Surgical Resection Following Carbon‐Ion Radiotherapy for Pancreatic Cancer With Arterial Involvement

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 6, Page 1788-1797, November 2026.
ABSTRACT Aim Carbon‐ion radiotherapy (CIRT) provides superior dose distribution and higher biological effectiveness than conventional X‐ray radiotherapy and has emerged as a promising component of multidisciplinary treatment for advanced pancreatic ductal adenocarcinoma (PDAC).
Kenichiro Araki   +9 more
wiley   +1 more source

When biliary-gastric fistula mimics double gallbladder: a diagnostic challenge in acute cholecystitis. [PDF]

open access: yesJ Surg Case Rep
El Bouazizi Y   +9 more
europepmc   +1 more source

Human gastric function : an experimental study of a man and his stomach /

open access: yes, 1944
"Tom", a man who had a gastric fistula from the age of 9 allowed important experiments on his gastric function.Includes bibliographical references and index."Tom", a man who had a gastric fistula from the age of 9 allowed important experiments on his ...
Wolf, Stewart,1914-2005   +2 more
core  

Current Status and Future Perspectives of Robotic Surgery for Esophagogastric Cancer in Asia

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 6, Page 1685-1690, November 2026.
ABSTRACT Robotic‐assisted surgery (RAS) has moved from an experimental adjunct to an increasingly established component of gastrointestinal (GI) oncological practice in parts of Asia, a region that carries a disproportionately high burden of gastric and esophageal cancer. Asian surgeons have been among the earliest and most prolific contributors to the
Jia Jun Ang, Jimmy Bok Yan So
wiley   +1 more source

Mucormycosis Causing Splenic Infarction, Gastric Fistula, and Brain Abscess in a Patient With Acute Myeloid Leukemia: A Case Report. [PDF]

open access: yesCase Rep Infect Dis
S da Silveira F   +7 more
europepmc   +1 more source

Investigating Risk Factors for Delayed Melanoma Recurrence Beyond 5 Years Post‐Primary Tumor Diagnosis

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Patients undergoing treatment for cutaneous melanoma are generally considered cured after a period of 5 years, since most recurrences manifest within three to 5 years. However, some patients can present with a delayed recurrence of melanoma beyond a 10‐year timeframe.
Kaspar Itin   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy